Levetiracetam in pediatrics (Q36081844)

12 August 2017

1 reference

title

Levetiracetam in pediatrics (English)

1 reference

12 August 2017

1 reference

Federico Vigevano

1

1 reference

12 August 2017

publication date

1 February 2005

1 reference

Journal of Child Neurology

12 August 2017

published in

1 reference

12 August 2017

volume

20

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

87-93

1 reference

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

ucb L059, a novel anti-convulsant drug: pharmacological profile in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Pharmacokinetics of levetiracetam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Pharmacokinetic study of levetiracetam in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Absence of Pharmacokinetic Drug Interaction of Levetiracetam with Phenytoin in Patients with Epilepsy Determined by New Technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Efficacy of levetiracetam: a review of three pivotal clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

The 'number needed to treat' with Levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Levetiracetam in refractory pediatric epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Suppression of cortical myoclonus by levetiracetam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Levetiracetam monotherapy for primary generalised epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Levetiracetam for benign epilepsy of childhood with centrotemporal spikes-three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

Levetiracetam psychosis in children with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738050200020101

10.1177/08830738050200020101

21 January 2018

Identifiers

DOI

1 reference

release_2wspeaax4fghhcjgmn27xhpqru

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2wspeaax4fghhcjgmn27xhpqru

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference